Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
Most adults over 75 who receive an RSV vaccine (Arexvy, Abrysvo, or mResvia) experience only mild, short-lived reactions such as injection site pain, fatigue, muscle aches, headache, joint pain, and sometimes low-grade fever, typically resolving within one to three days. Less common but more serious concerns include Guillain-Barré syndrome, reported at roughly 1 to 2 cases per million doses, along with rare allergic reactions and atrial fibrillation signals seen in clinical trials. Older age, frailty, existing heart or lung conditions, and other same-day vaccinations can all influence how strongly side effects are felt. There are several important factors to weigh, including timing, revaccination guidance, and which symptoms warrant urgent care, so see below to understand more.
If you are already feeling unwell after a vaccine or unsure whether your symptoms are a normal reaction or something that needs attention, a free, instant, online symptom check can help you sort typical post-vaccine effects from warning signs and point you toward the right next step in minutes.
Last reviewed for medical accuracy: 09/23/2026
Respiratory Syncytial Virus (RSV) is a common respiratory virus that causes mild, cold-like symptoms in most people. However, adults over 75 face a higher risk of severe illness, hospitalization, and complications. In response, health authorities in the U.S. have approved RSV vaccines specifically designed for older adults. As with any vaccine, it’s helpful to know what to expect. Below, we explore the rsv vaccine side effects over 75 — what’s typical, what’s uncommon, and when to seek medical advice.
Most people aged 75 and older tolerate the RSV vaccine well. The side effects generally mirror those seen with other adult vaccines, like the flu shot or COVID-19 booster. Common, mild-to-moderate side effects include:
These reactions usually develop within 24–48 hours of vaccination and resolve on their own within one to three days. They signal that your immune system is responding and building protection against RSV.
In addition to the typical discomfort around the arm or mild flu-like symptoms, some adults over 75 may experience:
These side effects are generally short-lived. Drinking plenty of water, resting, and using a cool compress at the injection site can help ease discomfort.
Serious side effects from the RSV vaccine in older adults are very rare. However, it’s important to recognize them and seek prompt medical attention if they occur. Watch for:
If you or a caregiver notice any of these symptoms after vaccination, call emergency services or go to the nearest emergency department right away. These may be signs of a severe allergic reaction (anaphylaxis) or other serious conditions requiring immediate care.
Several factors can influence how older adults experience vaccine side effects:
Immune System Changes
As we age, our immune system responses can become less predictable. Some adults may notice fewer side effects because their immune system reacts more mildly. Others may feel stronger reactions as the body works to build protection.
Underlying Health Conditions
Chronic conditions like heart disease, diabetes or lung disease can affect how you feel after any vaccination. Always discuss your medical history with your healthcare provider before getting the RSV vaccine.
Medications
Certain medicines, such as blood thinners or immunosuppressants, may alter vaccine responses or interact with side effects like bruising at the injection site.
If you experience common post-vaccine symptoms, here are some practical tips:
Document your symptoms: note what you felt, when it started, and how long it lasted. This information can be helpful if you discuss your experience with a healthcare provider.
Even though most rsv vaccine side effects over 75 are mild, you should contact your doctor if you experience:
For non-urgent concerns or to learn more about your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide whether to seek in-person care.
Vaccination remains one of the most effective ways to reduce severe RSV infections, hospitalizations and complications in older adults. While rsv vaccine side effects over 75 can be uncomfortable, they are typically brief and manageable. By preventing serious RSV illness—such as pneumonia or exacerbations of chronic lung disease—the vaccine’s benefits far outweigh the risks of side effects for most healthy adults.
Before receiving the RSV vaccine, discuss the following with your doctor:
This conversation will help your provider determine the best timing for vaccination and prepare strategies to manage any side effects.
While rsv vaccine side effects over 75 are generally mild and short-lived, every individual is unique. If you notice any concerning or life-threatening symptoms after vaccination, do not hesitate to speak to a doctor or call emergency services. Your health and peace of mind are the top priority.
(References)
* Qiu X, Xu S, Lu Y, Luo Z, Yan Y, Wang C, Ji J. Development of mRNA vaccines against respiratory syncytial virus (RSV). Cytokine Growth Factor Rev. 2022 Dec;68:37-53. doi: 10.1016/j.cytogfr.2022.10.001. Epub 2022 Oct 13. PMID: 36280532.
* Papi A, Ison MG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Campora L, Dezutter N, de Schrevel N, Fissette L, David MP, Van der Wielen M, Kostanyan L, Hulstrøm V, AReSVi-006 Study Group. Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604. PMID: 36791160.
* Walsh EE, Pérez Marc G, Zareba AM, Falsey AR, Jiang Q, Patton M, Polack FP, Llapur C, Doreski PA, Ilangovan K, Rämet M, Fukushima Y, Hussen N, Bont LJ, Cardona J, DeHaan E, Castillo Villa G, Ingilizova M, Eiras D, Mikati T, Shah RN, Schneider K, Cooper D, Koury K, Lino MM, Anderson AS, Jansen KU, Swanson KA, Gurtman A, Gruber WC, Schmoele-Thoma B, RENOIR Clinical Trial Group. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5. PMID: 37018468.
* Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, Glanternik J, Snaggs H, Baber J, Zachariah P, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Duron Padilla M, Richmond PC, Koury K, Schneider K, Kalinina EV, Cooper D, Jansen KU, Anderson AS, Swanson KA, Gruber WC, Gurtman A, MATISSE Study Group. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5. PMID: 37018474.
* Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D, AReSVi-006 Study Group. Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons. Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010. PMID: 38253338; PMCID: PMC11175669.
* Phijffer EW, de Bruin O, Ahmadizar F, Bont LJ, Van der Maas NA, Sturkenboom MC, Wildenbeest JG, Bloemenkamp KW. Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes. Cochrane Database Syst Rev. 2024 May 2;5(5):CD015134. doi: 10.1002/14651858.CD015134.pub2. Epub 2024 May 2. PMID: 38695784; PMCID: PMC11064886.
* Roman F, Burny W, Ceregido MA, Laupèze B, Temmerman ST, Warter L, Coccia M. Adjuvant system AS01: from mode of action to effective vaccines. Expert Rev Vaccines. 2024 Jan-Dec;23(1):715-729. doi: 10.1080/14760584.2024.2382725. Epub 2024 Aug 5. PMID: 39042099.
* Simões EAF, Pahud BA, Madhi SA, Kampmann B, Shittu E, Radley D, Llapur C, Baker J, Pérez Marc G, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Padilla MD, Richmond PC, Sarwar UN, Baber J, Koury K, Lino MM, Kalinina EV, Li W, Cooper D, Anderson AS, Swanson KA, Gurtman A, Munjal I, MATISSE (Maternal Immunization Study for Safety and Efficacy) Clinical Trial Group. Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial. Obstet Gynecol. 2025 Feb 1;145(2):157-167. doi: 10.1097/AOG.0000000000005816. Epub 2025 Jan 2. PMID: 39746212; PMCID: PMC11731064.
* Kelleher K, Subramaniam N, Drysdale SB. The recent landscape of RSV vaccine research. Ther Adv Vaccines Immunother. 2025;13:25151355241310601. doi: 10.1177/25151355241310601. Epub 2025 Jan 10. PMID: 39802673; PMCID: PMC11724408.
* Scott J, Abers MS, Marwah HK, McCann NC, Meyerowitz EA, Richterman A, Fleming DF, Holmes EJ, Moat LE, Redepenning SG, Smith EA, Stoddart CJ, Sundaram ME, Ulrich AK, Alba C, Anderson CJ, Arpey MK, Borre E, Ladines-Lim J, Mehr AJ, Rich K, Watts C, Basta NE, Jarolimova J, Walensky RP, Dugdale CM. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026. N Engl J Med. 2025 Dec 4;393(22):2221-2242. doi: 10.1056/NEJMsa2514268. Epub 2025 Oct 29. PMID: 41160817.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.